Home/Filings/4/0001127602-23-025765
4//SEC Filing

Garner Thomas 4

Accession 0001127602-23-025765

CIK 0001062822other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 4:02 PM ET

Size

5.3 KB

Accession

0001127602-23-025765

Insider Transaction Report

Form 4
Period: 2023-10-09
Garner Thomas
SVP, Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-09+248,923248,923 total
    Exercise: $1.08Exp: 2033-10-09Common Stock (248,923 underlying)
Footnotes (1)
  • [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (10/9/2024) and vests 1/48th per month for each month of service thereafter.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001996325

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:02 PM ET
Size
5.3 KB